| pubmed-article:17762344 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C1122962 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C0449258 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C1135135 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C2587213 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C0868928 | lld:lifeskim |
| pubmed-article:17762344 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:17762344 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:17762344 | pubmed:dateCreated | 2007-8-31 | lld:pubmed |
| pubmed-article:17762344 | pubmed:abstractText | We report the cases of three patients with advanced non-small cell lung cancer responding to erlotinib after progression under gefitinib treatment. | lld:pubmed |
| pubmed-article:17762344 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17762344 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17762344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17762344 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17762344 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17762344 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:MaionePaoloP | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:RossiAntonioA | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:GalettaDomeni... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:GridelliCesar... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:FerraraCarmin... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:Del... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:GuerrieroCiro... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:NicolellaDari... | lld:pubmed |
| pubmed-article:17762344 | pubmed:author | pubmed-author:ColantuoniGui... | lld:pubmed |
| pubmed-article:17762344 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:17762344 | pubmed:volume | 2 | lld:pubmed |
| pubmed-article:17762344 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17762344 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17762344 | pubmed:pagination | 758-61 | lld:pubmed |
| pubmed-article:17762344 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:meshHeading | pubmed-meshheading:17762344... | lld:pubmed |
| pubmed-article:17762344 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17762344 | pubmed:articleTitle | Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer. | lld:pubmed |
| pubmed-article:17762344 | pubmed:affiliation | Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy. cgridelli@libero.it | lld:pubmed |
| pubmed-article:17762344 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17762344 | pubmed:publicationType | Case Reports | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17762344 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17762344 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17762344 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17762344 | lld:pubmed |
